Vasiliki A. Moragianni, MD, MSc

• Department of Obstetrics and Gynecology
• Abington Memorial Hospital
• Abington, Pennsylvania

This layer of fat serves as insulation and helps the baby regulate body temperature after birth muscle relaxant elderly cheap nimodipine online mastercard. The fetus continues to gain weight and grow in length until approximately 40 weeks muscle relaxant side effects cheap 30mg nimodipine visa. The location of these stem cells in the embryo is referred to as the neural plate spasms after stent removal buy discount nimodipine 30mg online. By the end of the third week spasms 1983 trailer cheap nimodipine 30 mg with mastercard, two ridges appear along the neural plate first forming the neural groove and then the neural tube muscle spasms zoloft cheap nimodipine 30 mg visa. By the end of the embryonic period spasms spinal cord injury order 30mg nimodipine visa, or week eight, the neural tube has further differentiated into the forebrain, midbrain, and hindbrain. Brain development during the fetal period involves neuron production, migration, and differentiation. From the early fetal period until midgestation, most of the 85 billion neurons have been generated and many have already migrated to their brain positions. Neurogenesis, or the formation of neurons, is largely completed after five months of gestation. One exception is in the hippocampus, which continues to develop neurons throughout life. Neurons that form the neocortex, or the layer of cells that lie on the surface of the brain, migrate to their location in an orderly way. Neural migration is mostly completed in the cerebral cortex by 24 weeks (Poduri & Volpe, 2018). Once in position, neurons begin to produce dendrites and axons that begin to form the neural networks responsible for information processing. Regions of the brain that contain the cell bodies are referred to as the gray matter because they look gray in appearance. The axons that form the neural pathways make up the white matter because they are covered in myelin, a fatty substance that is white in appearance. Although cell differentiation is complete at birth, the growth of dendrites, axons, and synapses continue for years. The developing child is most at risk for some of the severe problems during the first three months of development. Unfortunately, this is a time at which many mothers are unaware that they are pregnant. Today, we know many of the factors that can jeopardize the health of the developing child. Teratogens are environmental factors that can contribute to birth defects, and include some maternal diseases, pollutants, drugs and alcohol. Factors influencing prenatal risks: There are several considerations in determining the type and amount of damage that might result from exposure to a particular teratogen (Berger, 2005). For example, the ears and arms reach their critical periods at about 6 weeks after conception. If a mother exposes the embryo to certain substances during this period, the arms and ears may be malformed. This is suggested by fraternal twins exposed to the same prenatal environment, but they do not experience the same teratogenic effects. The genetic make up of the mother can also have an effect; some mothers may be more resistant to teratogenic effects than others. It is believed that the Y chromosome, which contains fewer genes than the X, may have an impact. Alcohol use during pregnancy is the leading preventable cause of intellectual disabilities in children in the United States (Maier & West, 2001). Alcohol consumption, particularly during the second month of prenatal development but at any point during pregnancy, may lead to neurocognitive and behavioral difficulties that can last a lifetime. When a pregnant woman smokes the fetus is exposed to dangerous chemicals including nicotine, carbon monoxide and tar, which lessen the amount of oxygen available to the fetus. A woman being exposed to secondhand smoke during pregnancy has also been linked to low birth weight infants. In addition, exposure to thirdhand smoke, or toxins from tobacco smoke that linger on clothing, furniture, and in locations where smoking has occurred, results in a negative impact on infantslung development. Rehan, Sakurai, and Torday (2011) found that prenatal exposure to thirdhand smoke played a greater role in altered lung functioning in children than exposure postnatally. Prescription/Over-the-counter Drugs: About 70% of pregnant women take at least one prescription drug (March of Dimes, 2016e). A woman should not be taking any prescription drug during pregnancy unless it was prescribed by a health care provider who knows she is pregnant. Some prescription drugs can cause birth defects, problems in overall health, and development of the fetus. Over-the-counter drugs are also a concern during the prenatal period because they may cause certain health problems. For example, the pain reliever ibuprofen can cause serious blood flow problems to the fetus during the last three months. It is difficult to completely determine the effects of a particular illicit drug on a developing child because most mothers who use, use more than one substance and have other unhealthy behaviors. These include smoking, drinking alcohol, not eating healthy meals, and being more likely to get a sexually transmitted disease. The use of cocaine is connected with low birth weight, stillbirths and spontaneous Source abortion. Heavy marijuana use is associated with problems in brain development (March of Dimes, 2016c). Other complications of illicit drug use include premature birth, smaller than normal head size, birth defects, heart defects, and infections. Additionally, babies born to mothers who use drugs may have problems later in life, including learning and behavior difficulties, slower than normal growth, and die from sudden infant death syndrome. Children of substance abusing parents are also considered at high risk for a range of biological, developmental, academic, and behavioral problems, including developing substance abuse problems of their own (Conners, et al. Women who use drugs or alcohol during pregnancy can cause serious lifelong harm to their child. Some people have advocated mandatory screenings for women who are pregnant and have a history of drug abuse, and if the women continue using, to arrest, prosecute, and incarcerate them (Figdor & Kaeser, 1998). The policy required patient education about the harmful effects of substance abuse during pregnancy. In July 2014, Tennessee enacted a law that allows women who illegally use a narcotic drug while pregnant to be prosecuted for assault if her infant is harmed or addicted to the drug (National Public Radio, 2015). According to the National Public Radio report, a baby is born dependent on a drug every 30 minutes in Tennessee, which is a rate three times higher than the national average. However, since the law took effect the number of babies born having drug withdrawal symptoms has not diminished. Critics contend that the criminal justice system should not be involved in what is considered a healthcare problem. Grossman and Slutsky (2017) found that babies born in Flint Michigan, an area identified with high lead levels in the drinking water, were premature, weighed less than average, and gained less weight than expected. Radiation can also build up in body areas close to the uterus, such as the bladder. This is why women are cautioned about the amount and type of fish they consume during pregnancy. Toxoplasmosis: the tiny parasite, toxoplasma gondii, causes an infection called toxoplasmosis. A healthy immune system can keep the parasite at bay producing no symptoms, so most people do not know they are infected. As a routine prenatal screening frequently does not test for the presence of this parasite, pregnant women may want to talk to their health-care provider about being tested. Toxoplasmosis can cause premature birth, stillbirth, and can result in birth defects to the eyes and brain. While most babies born with this infection show no Source symptoms, ten percent may experience eye infections, enlarged liver and spleen, jaundice, and pneumonia. To avoid being infected, women should avoid eating undercooked or raw meat and unwashed fruits and vegetables, touching cooking utensils that touched raw meat or unwashed fruits and vegetables, and touching cat feces, soil or sand. If women think they may have been infected during pregnancy, they should have their baby tested. Sexually Transmitted Diseases: Gonorrhea, syphilis, and chlamydia are sexually transmitted infections that can be passed to the fetus by an infected mother. Mothers should be tested as early as possible to minimize the risk of spreading these infections to their unborn child. There are some measures that can be taken to lower the chance the child will contract the disease. However, the long-term risks of prenatal exposure to the medication are not known. German measles (or rubella): Rubella, also called German measles, is an infection that causes mild flu-like symptoms and a rash on the skin. However, only about half of children infected have these symptoms, while others have no symptoms (March of Dimes, 2012a). If the mother contracts the disease during the first three months of pregnancy, damage can occur in the eyes, ears, heart or brain of the unborn child. Deafness is almost certain if the mother has German measles before the 11th week of prenatal development and can also cause brain damage. Women in the United States are much less likely to be afflicted with rubella, because most women received childhood vaccinations that protect her from the disease. Maternal Factors Mothers over 35: Most women over 35 who become pregnant are in good health and have healthy pregnancies. Some women over 35 choose special prenatal screening tests, such as a maternal blood screening, to determine if there are any health risks for the baby. Older parents are more confident, less stressed, and typically married providing family stability. Their children perform better on math and reading tests, and they are less prone to injuries or emotional troubles (Albert, 2013). According to Gregory (2007), older women are more stable, Source demonstrate a stronger family focus, possess greater self-confidence, and have more money. In fact, for every year a woman delays motherhood, she makes 9% more in lifetime earnings. Teenage Pregnancy: A teenage mother is at a greater risk for having pregnancy complications including anemia, and high blood pressure. Infants born to teenage mothers have a higher risk for being premature and having low birthweight or other serious health problems. Premature and low birthweight babies may have organs that are not fully developed which can result in breathing problems, bleeding in the brain, vision loss, and serious intestinal problems. Very low birthweight babies (less than 3 1/3 pounds) are more than 100 times as likely to die, and moderately low birthweight babies (between 3 1/3 and 5 pounds) are more than 5 times as likely to die in their first year, than normal weight babies (March of Dimes, 2012c). Reasons for these health issues include that teenagers are the least likely of all age groups to get early and regular prenatal care. Additionally, they may engage in negative behaviors including eating unhealthy food, smoking, drinking alcohol, and taking drugs. Gestational Diabetes: Seven percent of pregnant women develop gestational diabetes (March of Dimes, 2015b). Most pregnant women have their glucose level tested at 24 to 28 weeks of pregnancy. Gestational diabetes usually goes away after the mother gives birth, but it might indicate a risk for developing diabetes later in life. If untreated, gestational diabetes can cause premature birth, stillbirth, the baby having breathing problems at birth, jaundice, or low blood sugar. Babies born to mothers with gestational diabetes can also be considerably heavier (more than 9 pounds) making the labor and birth process more difficult. For expectant mothers, untreated gestational diabetes can cause preeclampsia (high blood pressure and signs that the liver and kidneys may not be working properly) discussed later in the chapter. Risk factors for gestational diabetes include age (being over age 25), being overweight or gaining too much 54 weight during pregnancy, family history of diabetes, having had gestational diabetes with a prior pregnancy, and race and ethnicity (African-American, Native American, Hispanic, Asian, or Pacific Islander have a higher risk). Eating healthy and maintaining a healthy weight during pregnancy can reduce the chance of gestational diabetes. Women who already have diabetes and become pregnant need to attend all their prenatal care visits, and follow the same advice as those for women with gestational diabetes as the risk of preeclampsia, premature birth, birth defects, and stillbirth are the same. High Blood Pressure (Hypertension): Hypertension is a condition in which the pressure against the wall of the arteries becomes too high. There are two types of high blood pressure during pregnancy, gestational and chronic.

This reviewer agrees with the assessment of causality as potentially related to the study medication quinine muscle relaxant trusted nimodipine 30mg. The patient was treated with steroids as well as antifungal spasms heat or ice purchase on line nimodipine, antiviral spasms left shoulder blade purchase nimodipine with american express, and antibiotic medications muscle relaxant yellow pill cheap nimodipine 30mg with amex, and was placed on a ventilator back spasms 5 weeks pregnant discount nimodipine 30mg free shipping. Twelve days after the initial diagnosis of pneumonitis muscle relaxant potency nimodipine 30 mg online, the patient developed hypotension and asystole during a central line replacement, and was unable to be resuscitated. The investigator assessed the event of pneumonitis as related to study drug, and the Applicant assessed the event as possibly related. Pulmonary embolism was assessed by the Applicant as possibly related, and pneumothorax was assessed as not related. Reported preferred terms included acute respiratory failure, pulmonary embolism, dyspnea, pleural effusion, pneumothorax, pleural effusion, pneumonia, and pulmonary edema. With the exception of the case of pneumonitis already discussed which occurred in the expanded access program, these cases were attributed to disease (lung metastases associated with pneumothorax or malignant pleural effusion) or distinct disease related processes (worsening of congestive heart failure, acute-on-chronic respiratory failure, infectious process). Given the presence of additional disease processes that may account for the observed pulmonary events, this reviewer agrees with the assessment that these cases of severe pulmonary adverse events are unlikely to be related to the study product. Two cases of acute renal failure were reported as serious adverse events; both events were Grade 3 and demonstrated recovery. Reasons for discontinuation during the efficacy phase included progressive disease (n=6), adverse events (n=8), death (n=3), lost to follow-up (n=2) and receipt of an alternative anticancer therapy (n=4). Adverse events causing discontinuation prior to the second therapeutic dose were primarily hematologic toxicities, and included thrombocytopenia (n=2), anemia (n=2), decreased white blood cells (n=2), nausea and vomiting (n=1), and multiple hematologic adverse events (thrombocytopenia, leukopenia, neutropenia, hemolytic anemia; n=1). Causes of death which prevented continued trial participation included renal failure secondary to disease/ascites (n=1), metabolic acidosis (n=1), and bowel perforation (n=1). Twenty-nine patients discontinued the study during the long-term follow-up phase; reasons included death (n=2), adverse events (n=6), progressive disease (n=10), receipt of an alternative anticancer therapy (n=8) and patient withdrawal of consent (n=3). Adverse events causing discontinuation during long-term follow-up included myelodysplastic syndrome (n=1) and metastatic colon cancer (n=1). Additional preferred terms, such as those representing salivary gland toxicities (dry mouth, salivary gland pain, salivary gland enlargement) and additional renal toxicities (kidney fibrosis, proteinuria, and glomerular filtration rate decreased) were added by this reviewer. The case of adenocarcinoma of the lung occurred in a patient who did not have prior treatment-related risk factors such as radiation; it is unclear whether additional risk factors such as smoking were present. Of these cases, 2 were assessed as related to the study product (event Grades 1 and 2). Of these cases, one (a Grade 2 event which occurred 22 days after treatment) was not resolved and resulted in a dose reduction. Among the additional reported renal adverse events, several (glomerular filtration rate decreased, hematuria) have a potential relationship to radiation toxicity. Confounded by hypotension, significant tumor burden and baseline mild renal impairment. Patient experienced hydronephrosis due to progressive retroperitoneal lymphadenopathy, which was recorded as resolved prior to onset of renal insufficiency. The gastrointestinal adverse events observed could be associated with the product (as suspected in the case of nausea and vomiting) or with the underlying disease (in the cases of constipation and abdominal pain), or both. An analysis of treatment-emergent adverse events by number of therapeutic doses administered was conducted. The exception was in the classinfections and infestations,which occurred in 38. The most common infections experienced included urinary tract infection, upper respiratory tract infection, candida infection, and sinusitis. Grade 3 or 4 chemistry abnormalities in more than 2% of patients included elevations in serum glucose, alkaline phosphatase (4. Grade 3-4 thrombocytopenia was seen in 50% of patients, with Grade 3-4 neutropenia and lymphopenia occurring in 59. Thirty three percent of patients demonstrated Grade 4 thrombocytopenia, and Grade 4 neutropenia and anemia were experienced by 16% and 7% of patients, respectively. The high incidence of low-grade elevation of clotting parameters may be related to nutritional deficiency of vitamin K in the setting of poor oral intake in patients with nausea and vomiting, and the use of anticoagulation as either prophylaxis or treatment of thromboses. Laboratory Evidence of Renal Impairment Thirty-eight percent of patients experienced an increase in creatinine, all of which were Grade 1 or 2. Only three of the 16 patients identified in this analysis had a reported adverse event of renal failure. Seven of these 16 patients (44%) had a history of type 1 or type 2 diabetes mellitus, including the patient who progressed to a severely decreased CrCl; all had a history of hypertension. The remaining 4 had subsequent measurements; two demonstrated recovery to baseline range of severity, and two demonstrated improvement but incomplete recovery at 12 months. A limitation to the analysis of renal failure is the lack of laboratory data beyond 12 months. A universal confounding factor in the assessment of renal dysfunction in this population is the presence of hypertension, often longstanding, which itself may contribute to the observed renal impairment. The laboratory abnormalities started to normalize within one week and did return to baseline (Grade 1). The patient experienced hypoglycemia and bleeding while taking warfarin for a deep venous thrombosis, and reported a 30 to 45-pound weight loss over the past few months. One month after the initial presentation, she was found unresponsive and admitted with hepatic encephalopathy; during the admission, liver imaging demonstrated multiple hepatic masses with right portal vein reversal of flow. Despite aggressive treatment, the patient continued to decline, with metabolic acidosis, persistent thrombocytopenia, and coagulopathy. The patient appears to have had progressive metastatic disease with liver involvement. No patients experienced systolic blood pressure >200 mm Hg or diastolic blood pressure greater than 110 mm Hg following infusion. All but one had an increase in the dose of an existing antihypertensive medication; one had a single intravenous dose of enalapril. Given the nearly universal presence of hypertension (controlled or uncontrolled) in this population, close monitoring is warranted to avoid sequelae of severe, uncontrolled hypertension. There were three arrhythmias reported as serious adverse events: ventricular tachycardia, tachycardia, and cardio-respiratory arrest (n= 1 each). Given the pathophysiology of the underlying disease (with catecholamine excess), assessment of the etiology of these events is difficult. Events that occurred in proximity to an infusion are more likely to be related; only one event occurred < 1 week after a therapeutic infusion. The drug elimination is primarily by the renal route, and renal impairment could likely increase the exposures. Thus, no accumulation is anticipated with the second therapeutic dose, as the therapeutic treatment consists of 2 single doses given at least 3 months apart. The literature data for commercial experience of these products do not suggest a cardiovascular risk. Bone marrow biopsy 9 months after the initial dose demonstrated refractory anemia with excess blasts, and cytogenetic analysis showed loss of chromosomes 3 and 5, gain of 22, and dicentric 17:20 translocation resulting in loss of 17p and 20q with a minor clone 13q deletion. His prior therapy included several cycles of cyclophosphamide, vincristine, and dacarbazine, as 131 (b) (6) well as radiation therapy. Reviewer note: this case was provided as part of the 90-day safety update and is not be reflected in cumulative analyses derived from datasets. Renal Failure Analysis of adverse event narratives for reported cases of renal failure are discussed in Significant Adverse Events in Section 8. Of these patients, all had an additional risk factor of hypertension, and 8/19 (42%) had diabetes mellitus. Of the reported adverse events of renal failure or acute kidney injury, most were mild and recovered. As previously noted, a limitation to the analysis of renal failure is the lack of laboratory data beyond 12 months. A universal confounding factor in the assessment of renal dysfunction in this population is the presence of hypertension, often severe and longstanding, which itself contributes to renal impairment. Given these observations and the potential for underlying renal impairment in this population, close monitoring of renal function warrants inclusion in product labeling. An average of these two values for each patient was converted to a percentage in the datasets. Over the course of the study, the value of patient-rated quality of life remained relatively stable. It should be noted that the number of patients for whom data was available was not 100%, and decreased from 57 to 48 over the 12-month period described above. The increase of <10% is unlikely to be clinically meaningful, but may represent stability in overall health and quality of life. Additional exploratory analyses were performed by the statistical reviewer in Section 21. These analyses are all limited by the size of the safety population and relevant subgroups. An analysis of the safety population by age revealed that patients >65 years of age experienced greater percentages of most adverse events. Human Reproduction and Pregnancy There were no reported exposures during pregnancy. Special consideration regarding radiation exposure in pediatric patients, namely greater absorbed radiation dose and a potential longer life expectancy, was included in the product labeling. This radiotherapeutic requires special licensing for handling, and will be administered in centers with specialized experience in the administration of radioactive products. Therefore, it is unlikely that drug abuse or any attendant medical issues will occur. Overdose is unlikely with proper administration since measurement of radioactivity is required prior to administration as defined in the product labeling. An overdose of the product would likely result in radiation-related toxicities consistent with those described in the product label, of potentially increased severity or duration dependent upon the dose administered. The majority of cases were highly confounded by prior therapies with known associations with secondary malignancies including leukemia and myelodysplasia. A post-marketing study to evaluate the incidence of secondary malignancies will be conducted by the Applicant; refer to Section 15 Postmarketing Requirements and Commitment, for details. In the pooled safety population, 7% (n=6) of patients developed acute myeloid leukemia, acute lymphoblastic leukemia, or myelodysplastic syndrome. The risk for development of secondary malignancies will be included in product labeling, and a post-marketing requirement to further assess the risk of secondary malignancy will be performed by the Applicant. Myelosuppression was also a prominent, and expected, safety signal in the pooled safety population. Most patients experienced a decrease in one or more cell lines, and severe decreases in platelets and neutrophils were common (50% and 59%, respectively). The patient did not have pulmonary metastases, which would be expected to increase the risk of radiation toxicity to the lungs. Limited information regarding the expected incidence of or risk factors for radiation pneumonitis can be extrapolated from this single case. Hypothyroidism occurred in 2% (n=2) of patients; there were no reports of thyroid neoplasia, though this has been reported in the literature. Hypothyroidism is managed with appropriate monitoring and thyroid hormone replacement. Combined, durable response in hypertension as measured by the primary endpoint and confirmed objective response are measures of direct clinical benefit in this population. Myelosuppression and gastrointestinal adverse reactions were the most common adverse effects by system organ class. The risk of myelodysplastic syndrome and leukemia was less common, occurring in 7% of the pooled safety population. In addition, the safety profile of the drug is deemed acceptable for the indicated population of patients. The study was not designed to assess radiation toxicities occurring beyond 60 days, precluding a complete safety review of this study. Given the substantial unmet medical need in this rare population, the product should be indicated for patients ages 12 and older. The the radiation reference to specific organ limits referenced were based limits was removed in favor on a widely cited literature of using updated guidelines source from 1991. A new table (Table 1) to provide the absorbed-dose threshold values for radiation toxicity in critical organs. Exposure, safety and effectiveness are likely to be the same in adolescent patients. None of the safety signals identified during the review require a Risk Evaluation and Mitigation Strategy. Submit cumulative, integrated safety analyses after 5 and after 10 years of follow-up of patients from an adequate number of clinical trials to identify and characterize the risks of myelodysplastic syndrome, acute leukemia and other secondary malignancies with Azedra; include incidence rates, time to onset, predisposing factors, and outcomes. These safety evaluations should be adequate to inform labeling of patient populations at highest risk and to provide evidence-based dose modifications and monitoring recommendations. Nevertheless, I will summarize my thoughts regarding certain pertinent aspects of the application. Orphan Indication: Malignant pheochromocytoma (and paraganglioma) is an ultrarare disease that can result in morbidity or mortality either due to the underlying tumor burden or due to excess catecholamine hormone production.

Mast cells spasms hand discount nimodipine 30 mg overnight delivery, whose blood-borne precursors are not well defined muscle relaxant hair loss buy nimodipine uk, also differentiate in the tissues muscle relaxant egypt cheap nimodipine 30 mg line. They mainly reside near small blood vessels and spasms with broken ribs buy nimodipine 30 mg with visa, when activated spasms hands fingers order nimodipine 30 mg overnight delivery, release substances that affect vascular permeability spasms sternum buy cheap nimodipine line. Although best known for their role in orchestrating allergic responses, they are believed to play a part in protecting mucosal surfaces against pathogens. The granulocytes are so called because they have densely staining granules in their cytoplasm; they are also sometimes called polymorphonuclear leukocytes because of their oddly shaped nuclei. There are three types of granulocyte, all of which are relatively short lived and are produced in increased numbers during immune responses, when they leave the blood to migrate to sites of infection or inflammation. Neutrophils, which are the third phagocytic cell of the immune system, are the most numerous and most important cellular component of the innate immune response: hereditary deficiencies in neutrophil function lead to overwhelming bacterial infection, which is fatal if untreated. Eosinophils are thought to be important chiefly in defense against parasitic infections, because their numbers increase during a parasitic infection. The function of basophils is probably similar and complementary to that of eosinophils and mast cells; we shall discuss the functions of these cells in Chapter 9 and their role in allergic inflammation in Chapter 12. Macro-phages and neutrophils are primarily phagocytic cells that engulf pathogens and destroy them in intracellular vesicles, a function they perform in both innate and adaptive immune responses. The other myeloid cells are primarily secretory cells that release the contents of their prominent granules upon activation via antibody during an adaptive immune response. Mast cells are tissue cells that trigger a local inflammatory response to antigen by releasing substances that act on local blood vessels. The common lymphoid progenitor gives rise to the lymphocytes, with which most of this book will be concerned. There are two major types of lymphocyte: B lymphocytes or B cells, which when activated differentiate into plasma cells that secrete antibodies; and T lymphocytes or T cells, of which there are two main classes. One class differentiates on activation into cytotoxic T cells, which kill cells infected with viruses, whereas the second class of T cells differentiates into cells that activate other cells such as B cells and macrophages. Most lymphocytes are small, featureless cells with few cytoplasmic organelles and much of the nuclear chromatin inactive, as shown by its condensed state. This appearance is typical of inactive cells and it is not surprising that, as recently as the early 1960s, textbooks could describe these cells, now the central focus of immunology, as having no known function. Indeed, these small lymphocytes have no functional activity until they encounter antigen, which is necessary to trigger their proliferation and the differentiation of their specialized functional characteristics. Note the condensed chromatin of the nucleus, indicating little trans criptional activity, the relative absence of cytoplasm, and the small size. Lymphocytes are remarkable in being able to mount a specific immune response against virtually any foreign antigen. This is possible because each individual lymphocyte matures bearing a unique variant of a prototype antigen receptor, so that the population of T and B lymphocytes collectively bear a huge repertoire of receptors that are highly diverse in their antigen-binding sites. Antibody molecules as a class are known as immunoglobulins, usually shortened to Ig, and the antigen receptor of B lymphocytes is therefore also known as membrane immunoglobulin (mIg). We shall describe the structures of these lymphocyte antigen receptors in detail in Chapters 3, 4, and 5, and the way in which their diversity of binding sites is created as lymphocytes develop in Chapter 7. A third lineage of lymphoid cells, called natural killer cells, lack antigenspecific receptors and are part of the innate immune system. These cells circulate in the blood as large lymphocytes with distinctive cytotoxic granules. They are able to recognize and kill some abnormal cells, for example some tumor cells and virus-infected cells, and are thought to be important in the innate immune defense against intracellular pathogens. These are large granular lymphocyte-like cells with important functions in innate immunity. Although lacking antigen-specific receptors, they can detect and attack certain virus-infected cells. The lymphoid organs are organized tissues containing large numbers of lymphocytes in a framework of nonlymphoid cells. In these organs, the interactions lymphocytes make with nonlymphoid cells are important either to lymphocyte development, to the initiation of adaptive immune responses, or to the sustenance of lymphocytes. Lymphoid organs can be divided broadly into central or primary lymphoid organs, where lymphocytes are generated, and peripheral or secondary lymphoid organs, where adaptive immune responses are initiated and where lymphocytes are maintained. The central lymphoid organs are the bone marrow and the thymus, a large organ in the upper chest; the location of the thymus, and of the other lymphoid organs, is shown schematically in. The peripheral lymphoid organs are the sites of lymphocyte activation by antigen, and lymphocytes recirculate between the blood and these organs until they encounter antigen. Lymphoid tissue is also associated with other mucosa such as the bronchial linings (not shown). Both B and T lymphocytes originate in the bone marrow but only B lymphocytes mature there; T lymphocytes migrate to the thymus to undergo their maturation. Thus B lymphocytes are so-called because they are bone marrow derived, and T lymphocytes because they are thymus derived. Once they have completed their maturation, both types of lymphocyte enter the bloodstream, from which they migrate to the peripheral lymphoid organs. The peripheral lymphoid organs are specialized to trap antigen, to allow the initiation of adaptive immune responses, and to provide signals that sustain recirculating lymphocytes. Pathogens can enter the body by many routes and set up an infection anywhere, but antigen and lymphocytes will eventually encounter each other in the peripheral lymphoid organs the lymph nodes, the spleen, and the mucosal lymphoid tissues (see. Lymphocytes are continually recirculating through these tissues, to which antigen is also carried from sites of infection, primarily within macrophages and dendritic cells. Within the lymphoid organs, specialized cells such as mature dendritic cells display the antigen to lymphocytes. The lymph nodes are highly organized lymphoid structures located at the points of convergence of vessels of the lymphatic system, an extensive system of vessels that collects extracellular fluid from the tissues and returns it to the blood. This extracellular fluid is produced continuously by filtration from the blood, and is called lymph. Afferent lymphatic vessels drain fluid from the tissues and also carry antigen-bearing cells and antigens from infected tissues to the lymph nodes, where they are trapped. In the lymph nodes, B lymphocytes are localized in follicles, with T cells more diffusely distributed in surrounding paracortical areas, also referred to as T-cell zones. Some of the B-cell follicles include germinal centers, where B cells are undergoing intense proliferation after encountering their specific antigen and their cooperating T cells. B and T lymphocytes are segregated in a similar fashion in the other peripheral lymphoid tissues, and we shall see that this organization promotes the crucial interactions that occur between B and T cells upon encountering antigen. As shown in the diagram on the left, a lymph node consists of an outermost cortex and an inner medulla. These reactions are very dramatic, but eventually die out as senescent germinal centers. The bulk of the spleen is composed of red pulp, which is the site of red blood cell disposal. The schematic at top right shows that the spleen consists of red pulp (pink areas in the top panel), which is a site of red blood cell destruction, interspersed with lymphoid white pulp. The light micrograph at bottom left shows a transverse section of white pulp stained with hematoxylin and eosin. The lymphocytes form a follicle consisting of a large central dome of B lymphocytes surrounded by smaller numbers of T lymphocytes. Collectively, the mucosal immune system is estimated to contain as many lymphocytes as all the rest of the body, and they form a specialized set of cells obeying somewhat different rules. Although this tissue looks very different from other lymphoid organs, the basic divisions are maintained. Although very different in appearance, the lymph nodes, spleen, and mucosal-associated lymphoid tissues all share the same basic architecture. Each of these tissues operates on the same principle, trapping antigen from sites of infection and presenting it to migratory small lymphocytes, thus inducing adaptive immune responses. The peripheral lymphoid tissues also provide sustaining signals to the lymphocytes that do not encounter their specific antigen, so that they continue to survive and recirculate until they encounter their specific antigen. This is important in maintaining the correct numbers of circulating T and B lymphocytes, and ensures that only those lymphocytes with the potential to respond to foreign antigen are sustained. Small B and T lymphocytes that have matured in the bone marrow and thymus but have not yet encountered antigen are referred to as naive lymphocytes. These cells circulate continually from the blood into the peripheral lymphoid tissues, which they enter by squeezing between the cells of capillary walls. In the event of an infection, lymphocytes that recognize the infectious agent are arrested in the lymphoid tissue, where they proliferate and differentiate into effector cells capable of combating the infection. Here, they may encounter their specific antigen, draining from an infected site in the foot. These are called draining lymph nodes, and are the site at which lymphocytes may become activated by encountering their specific ligand. When an infection occurs in the periphery, for example, large amounts of antigen are taken up by dendritic cells which then travel from the site of infection through the afferent lymphatic vessels into the draining lymph nodes (see. In the lymph nodes, these cells display the antigen to recirculating T lymphocytes, which they also help to activate. B cells that encounter antigen as they migrate through the lymph node are also arrested and activated, with the help of some of the activated T cells. Once the antigen-specific lymphocytes have undergone a period of proliferation and differentiation, they leave the lymph nodes as effector cells through the efferent lymphatic vessel (see. Because they are involved in initiating adaptive immune responses, the peripheral lymphoid tissues are not static structures but vary quite dramatically depending upon whether or not infection is present. The diffuse mucosal lymphoid tissues may appear in response to infection and then disappear, whereas the architecture of the organized tissues changes in a more defined way during an infection. For example, the B-cell follicles of the lymph nodes expand as B lymphocytes proliferate to form germinal centers (see. Immune responses are mediated by leukocytes, which derive from precursors in the bone marrow. A pluripotent hematopoietic stem cell gives rise to the lymphocytes responsible for adaptive immunity, and also to myeloid lineages that participate in both innate and adaptive immunity. Neutrophils, eosinophils, and basophils are collectively known as granulocytes; they circulate in the blood unless recruited to act as effector cells at sites of infection and inflammation. Macrophages and mast cells complete their differentiation in the tissues where they act as effector cells in the front line of host defense and initiate inflammation. Macrophages phagocytose bacteria, and recruit other phagocytic cells, the neutrophils, from the blood. Mast cells are exocytic and are thought to orchestrate the defense against parasites as well as triggering allergic inflammation; they recruit eosinophils and basophils, which are also exocytic. Dendritic cells enter the tissues as immature phagocytes where they specialize in ingesting antigens. There are two major types of lymphocyte: B lymphocytes, which mature in the bone marrow; and T lymphocytes, which mature in the thymus. The bone marrow and thymus are thus known as the central or primary lymphoid organs. Mature lymphocytes recirculate continually from the bloodstream through the peripheral or secondary lymphoid organs, returning to the bloodstream through the lymphatic vessels. Most adaptive immune responses are triggered when a recirculating T cell recognizes its specific antigen on the surface of a dendritic cell. Adaptive immune responses are initiated in these peripheral lymphoid tissues: T cells that encounter antigen proliferate and differentiate into antigen-specific effector cells, while B cells proliferate and differentiate into antibody-secreting cells. The macrophages and neutrophils of the innate immune system provide a first line of defense against many common microorganisms and are essential for the control of common bacterial infections. However, they cannot always eliminate infectious organisms, and there are some pathogens that they cannot recognize. The lymphocytes of the adaptive immune system have evolved to provide a more versatile means of defense which, in addition, provides increased protection against subsequent reinfection with the same pathogen. The cells of the innate immune system, however, play a crucial part in the initiation and subsequent direction of adaptive immune responses, as well as participating in the removal of pathogens that have been targeted by an adaptive immune response. Moreover, because there is a delay of 4 7 days before the initial adaptive immune response takes effect, the innate immune response has a critical role in controlling infections during this period. Most infectious agents induce inflammatory responses by activating innate immunity. Microorganisms such as bacteria that penetrate the epithelial surfaces of the body for the first time are met immediately by cells and molecules that can mount an innate immune response. Phagocytic macrophages conduct the defense against bacteria by means of surface receptors that are able to recognize and bind common constituents of many bacterial surfaces. Bacterial molecules binding to these receptors trigger the macrophage to engulf the bacterium and also induce the secretion of biologically active molecules. Activated macrophages secrete cytokines, which are defined as proteins released by cells that affect the behavior of other cells that bear receptors for them. They also release proteins known as chemokines that attract cells with chemokine receptors such as neutrophils and monocytes from the bloodstream. The cytokines and chemokines released by macrophages in response to bacterial constituents initiate the process known as inflammation. Local inflammation and the phagocytosis of invading bacteria may also be triggered as a result of the activation of complement on the bacterial cell surface. Complement is a system of plasma proteins that activates a cascade of proteolytic reactions on microbial surfaces but not on host cells, coating these surfaces with fragments that are recognized and bound by phagocytic receptors on macrophages. The cascade of reactions also releases small peptides that contribute to inflammation. They also produce chemokines that direct the migration of neutrophils to the site of infection. The stickiness of the endothelial cells of the blood vessels is also changed, so that cells adhere to the blood vessel wall and are able to crawl through it; first neutrophils and then monocytes are shown entering the tissue from a blood vessel. Later in an immune response, activated lymphocytes may also contribute to inflammation.

This is sometimes difficult muscle relaxant high blood pressure cheap 30 mg nimodipine visa, especially if one does chlorpromazine or haloperidol]) or muscle relaxant 5658 discount 30 mg nimodipine overnight delivery, most commonly spasms colon nimodipine 30mg generic, a not have a reliable history regarding the length of earlier combination of a mood stabilizer plus one of the antipsy episodes muscle relaxant long term use purchase nimodipine 30mg overnight delivery. Although there are no hard and fast guidelines for toms spasms catheter buy nimodipine 30 mg low price, no matter how mild gas spasms discount 30 mg nimodipine with mastercard, treatment should be continued, choosing which agent or agents to use, some general guide and in general it is best to hold off on discontinuing treat lines may be offered. Lacking phase of treatment, some further words are in order such a history, and assuming that there are no significant regarding lithium. If lithium was used during the acute contraindications, then one should consider either lithium phase it may be necessary to reduce the dose once symp or divalproex; although lithium has by far the longest track toms have been brought under control; in many patients, record, divalproex is extraordinarily easy to use and may even though the dose of lithium is held constant, the blood have an edge over lithium in mixed episodes. Another defi level will rise as symptoms come under control, and nite advantage of divalproex is the rapidity of response patients may develop significant, and unexpected, side when aloadingstrategy is used, with patients often show effects. Furthermore, if lithium was used during continua ing a response within a matter of days, in contrast to the tion treatment and the decision is to forego preventive week or twolag periodseen with lithium. Carbamazepine treatment, then the dose of lithium should be tapered is not as well tolerated as either divalproex or lithium, and gradually over a few weeks, as it appears that abrupt dis may be a little less effective than lithium. Among the continuation of lithium may predispose to a recurrence of antipsychotics, the first choice is probably olanzapine, as it mania (Baldessarini et al. However, if for has not been demonstrated for divalproex or carba some reason chronic treatment with an antipsychotic is mazepine, prudence dictates following a similar strategy. Frequent episodes, perhaps occurring more occurred, one typically has to use a combination of a mood than once every 2 years, usually constitute an indication for stabilizer plus an antipsychotic. In this regard, given the relative ineffective Severe episodes, however, even if infrequent, may warrant ness of lamotrigine as an anti-manic agent, if one is adding an prevention. In cases in which episodes develop very slowly, antidepressant it is prudent to have one of the other mood patients may be able tocatchthemselves in time, and stabilizers. The choice of an antidepressant is discussed in Section in which episodes come on acutely, however, patients may 20. If possible, some clinicians prefer avoiding the use of be defenseless and thus in need of preventive treatment. The optimum pre Once depressive symptoms have been relieved, treat ventive doses for divalproex and carbamazepine have not ment should be continued to prevent a reappearance of been determined; prudence suggests continuing the same symptoms. If the depression has responded to a mood sta dose as was effective in the continuation phase of treatment. Deciding when to status and good compliance, consideration may be given to discontinue an antidepressant is not straightforward. Lacking this guid as olanzapine for preventive treatment; however, although ance, however, one may wish to wait until the patient has this is becoming increasingly popular, caution may be nec been euthymic for a significant period of time, at least essary for two reasons. First, although olanzapine has been weeks, before attempting a discontinuation; should symp shown to be effective in this regard, its track record is not toms recur, then one may simply restart the antidepressant. Second, this may be Once the current depressive episode has run its course, a problematic option if the potential long-term side-effects patients may be considered for preventive treatment with a of olanzapine occur, such as weight gain, diabetes, and mood stabilizer: carbamazepine, lithium, or lamotrigine hyperlipidemia. If patients are not bipolar disorder, the most important decision to make is already taking a mood stabilizer, one should be started; in which drug to use over the long haul. Although not with this regard, although lamotrigine has not been shown to be out controversy, it is probably appropriate to consider one effective in the acute treatment of mania, it is effective in the of the mood stabilizers for long-term treatment. If the patient is taking lithium the mood stabilizers, lithium remains theone to beatas it or divalproex and a depression occurs, it may be appropriate is effective in all phases of treatment; carbamazepine is also to switch to either carbamazepine or lamotrigine, as these effective in all phases but its side-effect burden is typically may be more effective against depression. Divalproex is a reasonable choice for effectiveness of this strategy, one must keep in mind that two mania-predominant cases of bipolar disorder; however, or more weeks may be required before depression lifts. Eventually, symptoms gradu depression, is characterized by the occurrence of one or ally undergo a more or less full remission. At times depressive episodes may appear to be precipi Synonyms for this disorder include unipolar affective disor tated by a stressful life event, typically a serious loss, such as der, melancholia, and manic-depressive illness, depressed the death of a loved one, divorce, or the loss of a job. Melancholia is the most depression on the separation, in fact it was the depressive ancient term for this disorder; it comes from the Greek prodrome that caused the separation. Manic-depressive illness, depressed times trigger depressive episodes, for they do. However, it type, the final synonym for this disorder, is problematic for appears that in this group of patients with precipitated two reasons. First, as originally conceived by Kraepelin, depressive episodes, subsequent episodes tend to become manic-depressive illness was a disorder that subsumed what independent and to occur autonomously without any pre today are recognized as two disorders, namely major cipitating events (Brown et al. Given the separateness of major depressive anhedonia; anergia; sleep disturbance; appetite distur disorder and bipolar disorder, however, it may no longer be bance; and psychomotor change. The second reason an overall diurnal variation in the severity of their depres has to do with common usage. Mood is typically depressed but may be primarily irrita Major depressive disorder is a common disorder, ble; some patients may also complain of anxiety. In some occurring in at least 5 percent of the general population; cases, however, although possessed of a depressed affect, amongst adults it is twice as common in women as in men. Although the first episode Self-esteem typically sinks and the workings of con of depression generally appears in the mid-twenties, the range science become prominent. Patients may consider them in age of onset is wide, from childhood to the ninth decade. Typically, there is a long prodrome, often lasting Indeed, in reviewing the past, patients seemblindto any months, characterized by fleeting and often indefinite symp accomplishments and fix only on their misdeeds and short toms such as moodiness, anxiety or fatigue. Furthermore, comings, which, as they recall them, may become magnified when the depressive episode finally does settle in, the various to heinous proportions. Some patients may give way to symptoms often appear haltingly and with differing severi rumination, in which their failings and defects repeat them ties, and it is consequently rare that a patient can date the selves again and again in a litany of hopelessness. This is not to say, however, is common and patients see no hope for the future; to them that acute and obvious onsets are not seen. As they lie awake, may be merely passive and patients may wish aloud that they many patients experience ruminations or restless, unpro might die of some disease or accident. When the morning finally does come, active, and patients may consider hanging or shooting them patients find themselves unrefreshed and exhausted, as if selves, jumping from bridges, or overdosing on their medica they had not slept at all. Often, and seemingly paradoxically, the risk of suicide insomnia, patients with major depressive disorder may is greatest as patients begin to recover. Still seeing themselves complain of hypersomnia, wherein they sleep excessively, as worthless and hopeless sinners, these patients, now with sometimes for up to 18 hours. When more severe, however, there may be same paragraph but never find themselves understanding hand-wringing and incessant pacing: patients may com what they read. Short-term memory may become difficult, plain that they cannot keep still; they may lament their fate and patients may be unable to recall where they put their keys out loud and give way to wailing and repetitive pleas for or what was said just minutes before. The tension of these patients may be extreme, almost simple ones, may become an almost insuperable task; every palpable, and yet, despite their piteous pleas for help, they thing appears too complicated, with too many possibilities cannot be comforted, no matter what is done for them. In some cases of severe depression in the elderly, Psychomotor retardation, although uncommon, may also cognitive decrements may be severe enough to constitute a occur. In severe cases patients may not move for any reason; Price 1982); a 66-year-old was disoriented to time and place, they may go without bathing or changing their clothes, and confused, and incontinent (Kramer 1982); both recovered some may defecate or urinate in the chair or on the bed. Delusions and hallucinations may occur in about 15 per Anhedonia manifests with a lack of interest in formerly cent of the depressive episodes of major depressive disorder, pleasurable activities; sports and hobbies, etc. Libido is routinely lost and there is fantastic way, they are appropriate to the patientsmoods no pleasure in sexual activity. Guilt may be extreme and patients Anergia manifests with a dearth of energy, and patients may confess to unspeakable sins: they have poisoned their may complain of feeling tired, fatigued, lifeless, or drained. Delusions of persecution are common and have a pecu tion; suchincreased energyis useless to the patient and is liar twist to them. In contrast to patients with schizophrenia, always overshadowed by a sense of imminent and impend who have delusions of persecution and protest that they are ing exhaustion. Delusions of what is technically known asinitialinsomnia, or trouble poverty and nihilistic delusions may also occur and are falling asleep, the most characteristic kind of insomnia in entirely consistent with these patientsviews of themselves as depression comes later in the night as eithermiddleor worthless and hopeless. In middle insomnia the patient awak out any funds and are completely bankrupt and unable to ens in the middle of the night for no particular reason and pay any bills, and that their families will go destitute. Those then has great difficulty falling back to sleep, often lying with nihilistic delusions may believe that they are near death: awake for an hour or more before sleep finally comes. Events may also lucinations may also occur and generally reflect the patientsserve as precipitants for episodes in adult life; however, as delusions. Voices may accuse them of crimes or sins, or noted earlier, the importance of precipitants fades with announce that their well-deserved punishment is at hand. In some cases patients may There is abundant evidence for endocrinologic distur develop stuporous catatonia (Starkstein et al. Within the hypothalamus, for example, episodes include anxiety attacks (Van Valkenburg et al. As noted earlier, in about 50 percent of cases, depressive the undoubted success of antidepressant medications has episodes will undergo a spontaneous remission within focused attention on biogenic amines. The duration of the interval between succes pressants have effects on either noradrenergic or serotonin sive episodes ranges widely, from as little as 1 year up to ergic functioning, it appears reasonable to assume that there decades, with an overall average of about 5 years. In gen is a complementary disturbance in these amines in patients eral, however, with repeated episodes the interval between with major depressive disorder. Despite enormous research episodes tends to shorten, and the episodes themselves efforts, however, it has been difficult to isolate definite abnor tend to lengthen, such that, over a very long period of time, malities here. One notable exception involves the effects of successive episodes may eventuallymergeto create a tryptophan depletion. Some studies have suggested changes in the dorsolateral prefrontal cortex; however, in my opinion the endocrinologic and sleep abnormalities Etiology point rather to the diencephalon or brainstem as the most likely sites for any changes. In this regard, several, albeit Hereditary factors appear to play a role: the prevalence of preliminary, findings have been reported, including the major depression is higher in the relatives of patients than following; an increased number of neurons in the of control subjects, and the monozygotic concordance rate mediodorsal nucleus of the thalamus (Young et al. To date, however, genetic studies have not ventricular nucleus of the hypothalamus (Manaye et al. With Hereditary factors, although clearly important, do this caveat in mind, however, it may be reasonable to propose not appear to provide a complete account, and environ that major depressive disorder represents an interaction mental factors also seem to play a role. A personal history of a good response to a particular Differential diagnosis agent is a good predictor of future response, and a family history of a good response may also predict a good response, the first step in differential diagnosis is to ensure that the but this relationship may not be as robust. Sedation may be prob lematic with tricyclics (with the exception of nortriptyline, the overall pharmacologic treatment of major depressive desipramine, and protriptyline), mirtazapine, and trazodone, disorder is conveniently divided into three phases: acute but is generally negligible with the other agents. Regardless depressive symptoms of such severity as to preclude inde of which agent is chosen it must be given anadequatetrial, pendent functioning at home and work; significant con which involves not only anadequatedose but also anade current illness that requires inpatient monitoring; and a quateduration. If there is improvement by the fourth week, then the a large miscellaneous group (including duloxetine, venlafax patient should be advised that it may take up to 3 months to ine, mirtazapine, bupropion, and trazodone). If the patient is Before leaving this discussion of the acute treatment of euthyroid, and the side-effect burden is readily tolerable, depression, some words are in order regarding certain one may at this point consider simply increasing the dose; other treatments, including herbal remedies. Johns wort and omega-3 fatty acids reasonable strategy to gradually push the dose to the maxi may be beneficial in mild depressions, but cannot be mum recommended, waiting weeks each time to see if there counted on in anything more severe. Switching antidepressants is a viable ries such a significant risk of neuroadaptation that most option but in doing so one should probably switch to an clinicians shy away from using it. This last option is depression, merely suppress symptoms, and consequently if potentially dangerous and should probably only be under treatment is discontinued before the depressive episode has taken by a specialist. Regardless of whether one switches or run its course, symptoms will gradually recur. How far one goes with this one of the agents); however, this must be carried out care approach depends largely on the severity of the depression. Continuation treatment should persist for the duration Although the foregoing schema for the acute treatment of of the depressive episode. In cases in which the patient has a depression is in general applicable to most cases, exceptions history of depressive episodes of fairly uniform and discrete do occur. First, in severe cases requiring hospitalization, duration, this may be used as a guide for determining the many physicians will routinely check thyroid status and begin length of continuation treatment. In these cases, continuation treat not only the most effective treatment for depression but also, ment should probably be performed until the patient has with proper technique, remains quite safe. Third, there is been symptom free for 6 consecutive months (Altamura some controversy regarding the treatment ofpsychotic and Percudani 1993; Kupfer et al. When the time does come to consider voluntarily isolate themselves, and family members may discontinuation of treatment, given that a small risk of soon learn toleave well enough aloneduring this part of relapse still exists, one may wish to schedule the discontin the menstrual cycle. Prevention should be strongly con Eventually, with menopause, the episodes cease to occur. If patients relationship to major depressive disorder, given that the do elect for maintenance therapy one may simply continue prevalence of major depressive disorder is higher in the rel the antidepressant regimen used in continuation therapy.

Discount 30 mg nimodipine with amex. Myo Fit Physiotherapy Gun / Muscle Relaxer Gun by Biotronix India Imported by Solution Forever.

Suspected polymorphic/mutated sites are then sequenced to verify the presence of such genetic variation spasms translation purchase 30 mg nimodipine with visa. In each reaction the sequencing primers bind and start the extension of the chain at the same place muscle relaxant lactation proven 30mg nimodipine. The extended chains spasms right side of body purchase nimodipine without a prescription, however spasms after surgery cheap nimodipine 30 mg with amex, terminate at different sites when dideoxynucleotides are incorporated spasms from spinal cord injuries quality 30 mg nimodipine. The complementary sequences which hybridize to the chip are determined by digital imaging spasms heart order nimodipine 30 mg online. Microarrays are very useful but they are also very misleading; better data analysis tools need to be developed to improve the accuracy of the microarrays. Modifying gene expression Gene function can often be studied by transferring the gene into a cell different from the one from which it was isolated. A mutated oncogene, isolated from a tumour cell, may be transfected into a normal cell to determine whether it causes malignant transformation. For all methods, the efficiency of transfer must be high enough for easy detection, and it must be possible to recognize and select for cells containing the newly introduced gene. It is usually necessary to select for retention of the transferred genes before assaying for expression. For this reason, a selectable gene, such as the gene encoding resistance to the antibiotic neomycin, can be introduced simultaneously by taking advantage of the fact that frequently cells that can take up one gene will also take up another. Adenovirus vectors take larger inserts and have a very high efficiency of transfer. Specific gene inactivation in this way has the potential for therapy of tumours; for example, by inhibiting the expression of an oncogene. A limitation of the above technologies is that a high concentration of molecules must be efficiently delivered to all the tumour cells and must persist inside the cells for a prolonged period of time. Once the nucleic acids enter a cell, they are vulnerable to a variety of cellular nucleases. Proteomics Proteomics is the large-scale study of proteins, particularly their structure and function. Protein separation: 2-dimensional electrophoresis separates proteins based on size, as in regular electrophoresis, but also based on charge, or isoelectric point (pI). The mixed protein sample is run on an immobilized pH gradient; the range of the gradient used depends on the expected proteins in the sample. When the protein is at the point in the gradient where the surrounding pH is equal to its pI, there will be no charge on the protein and it will stop moving. Once the proteins have been separated, they can be analyzed quantitatively as long as there is a reference sample. Proteins that are expressed at different levels are then taken for further analysis and identification. Protein identification by mass spectrometry: the spots are cut out of the gel and digested into smaller polypeptide fragments (5 to 10 amino acids) by enzymes. The polypeptide fragments are analyzed by mass spectrometry, which will give the molecular weight of each fragment. Once the masses of the fragments have been determined, they are run through a sequence database and compared to find the actual amino acid sequence, and thus identity, of the protein. This method of protein analysis also gives information on any post-translational modifications that have occurred, such as alternate splicing, glycosylation or phosphorylation. Monitoring expression by this method is useful for measuring levels of active proteins in a cell and may give clues to the metabolism, signaling or other activities of a cell under varying conditions. Cell signaling Changes in the physical or chemical environment of the cell results in responses are brought about by elaborate networks of intracellular signals, caused by changes in protein phosphorylation and enzymatic activity, localization, and the formation of protein-protein complexes. Cellular responses are triggered by the recognition of extracellular signals at the cell surface that result in the activation of linked cytoplasmic and nuclear biochemical pathways. These signal transduction pathways control cellular processes from cell proliferation and survival to specialized functions such as the immune response and angiogenesis. When they are dysregulated, normal signaling pathways contribute to malignant transformation in human cells. Extracellular growth factors Cellular regulation can occur through direct cell-to-cell contact or cell contact with its surrounding extracellular matrix, but much of our knowledge of signal transduction pathways comes from studying the interaction of soluble growth factors with complementary growth factor receptors expressed on responsive cells. Growth factors may be freely diffusible or can reside in spacially restricted domains either through binding to components in the extracellular matrix or because they are membrane-anchored molecules that reside on the surface of the producing cells. Receptors for growth factors are membrane-spanning cell surface molecules that share the ability to phosphorylate themselves and other cytoplasmic 63 proteins on tyrosine residues, thereby activating a signaling cascade. Binding of the growth factor or ligand induces conformational changes in the extracellular domain of the receptor that facilitates dimerization. The consequent conformational changes in the growth factor receptor bring together two intracellular catalytic domains, resulting in intermolecular autophosphorylation (transphosphorylation) of tyrosine residues. Increased expression is thought to increase the concentration of active dimers generating continuous and inappropriate cellular signaling. A unifying feature of cytoplasmic signaling proteins is the presence of one or more conserved noncatalytic domains that mediate sequence specific protein-protein interactions. Many of these domains bind specifically to short (typically less than 10 amino acids) contiguous regions of their target protein. Activation of growth factor receptors results in the autophosphorylation of the receptor at multiple tyrosine residues, and results in the creation of a number of docking sites for cytoplasmic proteins. The activity of both receptor and cytoplasmic tyrosine kinases is tightly regulated. The opposing action of protein tyrosine phosphatases can eliminate docking sites for proteins or inhibit tyrosine kinase activity by dephosphorylation of regulatory phosphorylation sites in the kinase activation loop. Regulation of receptor levels at the cell membrane is another mechanism used to regulate activity. The rapid removal of receptors from the cell surface by endocytosis allows a cell to return to an unstimulated, basal state after receiving and responding to a specific signal. Both H-ras and N-ras are also subsequently modified by the addition of two palmitoyl long chain fatty acids that are important for the correct localization of these proteins to specific membrane locations. Activation of these downstream pathways leads to cellular responses including gene transcription, cell cycle progression, and survival (Tannock et al. Phosphoinositide signaling pathways Phosphoinositides are phospholipids of cell membranes that are dynamically regulated in response to growth factor signalling. In response to growth factor signaling phosphoinositides can be phosphorylated or dephosphorylated by lipid kinases and phosphatases at distinct positions on the inositol ring. Transcriptional response to signaling Activation of signaling pathways leads to transcription of new genes that coordinate cell growth, cellular differentiation, cell death, and other biological effects. Transcription factor activity may also be enhanced through interaction with small molecules. Enzymes that regulate histone acetylation and phosphorylation are key components of transcriptional activator and repressor complexes. The acetylation status of histones, the core proteins of nucleosomes, can regulate gene expression by altering chromatin coiling. Methylation-induced transcriptional silencing begins early during the process of genetic instability and can affect many genes that are important in tumour progression. Given that methylation is a potentially reversible state, this creates a target for novel cancer therapeutic strategies involving gene reactivation. Oncogenes and tumour suppressor genes There is substantial evidence that multiple genes must be mutated or deregulated in a single cell to cause malignant transformation and cancer growth. Most cells that harbour even a single mutation are either targeted for repair or are cleared from the organism by protective mechanisms including immune surveillance or activation of cellular suicide programs (apoptosis). Not all mutations contribute to tumour development: the genetic material in each of our cells is estimated to encode approximately 30,000 genes, 67 and mutations in less than 10 percent of these genes contribute to the carcinogenic process. Genes that may contribute to tumourigenesis play key roles in regulating critical cellular processes such as cell division, lifespan, differentiation, angiogenesis, invasion, and death. Specific mutation of one allele converts the normal protooncogene to the activated, transforming oncogene that can contribute to the carcinogenic process. The oncogene is dominant over the protooncogene and generally results in a protein product that is deregulated and/or constitutively active. Oncogenic conversion is a gain to loss or inactivation of both alleles is required for transformation. Tumour suppressors are also known as recessive oncogenes or anti-oncogenes and their inactivation represents a loss-of-function mutation. Both oncogene activation and tumour suppressor inactivation collaborate in the stepwise progression to tumourigenesis. Here we will focus on these cancer genes and outline how they have been identified, the genetic abnormalities associated with deregulation, the nature of the specific gene products, their mechanisms of action, and recent advances to counteract these tumour-promoting lesions with novel anticancer therapeutics. Tumour suppressor genes Approximately 1 percent of all human cancers arise in individuals with a hereditary cancer syndrome. Even though such conditions are relatively rare, investigations of the affected individuals and of mutations of genes associated with their disease have proven invaluable in understanding the genetics and etiology of cancer. Most inherited cancer syndromes are a consequence of germline transmission of inactivating, loss-of-function mutations in tumour suppressor genes. Unlike oncogenes, whose mutations are associated with sporadic tumours and act in a dominant manner, mutations of tumour suppressor genes are recessive at the somatic level, and the remaining wild-type allele is inactivated during cancer development. Studies by Knudson investigating the epidemiology of familial retinoblastoma, an autosomal dominant hereditary form of retinal cancer led to the two hit hypothesis (Knudson, 2001), highlighting the importance of recessive mutations in tumourigenesis. In contrast to sporadic cases of retinoblastoma (Rb), patients with familial disease were likely to develop a more severe, bilateral or multifocal disease at an earlier age of onset. Based on these observations, Knudson proposed that two mutations, or two hits, were required for retinoblastoma to appear in both sporadic and familial cases. In familial retinoblastoma, the first mutation (in one of the alleles of the Rb gene) is transmitted through the germline and is present in all cells, whereas the second mutation needs to occur somatically. Thus a second hit (in the other allele of the Rb gene) in only one retinal cell is sufficient for the tumour to arise, in agreement with the dominant inheritance of familial retinoblastoma. In sporadic (noninherited) retinoblastoma, both mutations and hits have to occur within the same somatic cell, statistically a far less likely event. Genetic defects of tumour suppressor genes also occur frequently in sporadic cancer, both during tumour initiation and progression. Cytogenetic studies in lymphocytes of patients with familial cancers provided important information about the chromosomal location of tumour suppressor genes. For instance, 5 percent of retinoblastoma patients had interstitial deletions on chromosome 13q14, whereas Wilms tumour patients frequently had deletions on chromosome 11p13, pointing to the 68 chromosomal position of tumour suppressor genes associated with these diseases. Recent studies have indicated that small deletions and point mutations are more commonly found than large deletions in tumours. Information relating to genetic alterations in cancer can be accessed through an interactive, database cgap. Genetic material in all somatic cells is comprised of equal contributions of maternal and paternal chromosomal material. Loss of heterozygosity can also arise from a complete absence of the wild-type allele, as in the case of large deletions or partial or complete chromosomal loss. The p53 gene the p53 tumour suppressor gene is mutated in more than 50 percent of all human cancers and provides a selective growth advantage for cells harbouring its mutations. Genetic studies in mice have demonstrated that p53 is not essential for normal growth and development but mice carrying p53 mutations are highly susceptible to tumour development, particularly of lymphoid origin, confirming the role of p53 as a tumour suppressor. One of the most prominent transcriptional targets of p53 is p21 (Cip1/Waf1), a 21 kDa inhibitor of cyclin-dependent kinases important for proper G1-S cell cycle transition. Cells lacking p53 have an increased incidence of genetic instability and gene amplification. The transforming potential of these molecules is often directly dependent on their ability to interact with p53 and impair its function. Thus, molecules involved in the regulation of p53 form an elaborate oncogene-tumour suppressor gene network. The existence of such networks has been demonstrated for the majority of known tumour suppressor genes. Phosphorylation of the retinoblastoma protein (Rb) removes its restraining effect on the G1-to-S phase transition. Following M, cells may also enter a quiescent G0 phase in the absence of stimuli triggering further cell division cycles. In the presence of a sustained mitogenic stimulus, cells in G0 or G1 progress to a restriction point (R), beyond which a cell is committed to enter S phase. After the R point, growth factors present in the environment are no longer required for progression into S phase and completion of G2 and M phases. In cancer cells, deregulation of multiple control mechanisms results in cells with different degrees of autonomy from extracellular growth-stimulatory or growth-inhibitory signals, making them more likely to meet the requirements for transition through the R point. Progression through the cell cycle is coordinated by a tightly regulated series of events involving the synthesis, assembly, and activation of key cell cycle regulatory complexes comprised of cyclins and cyclin-dependent kinases (Cdks), followed by their subsequent disassociation and degradation. Multiple mechanisms regulate the timing of these processes, including transcriptional and translational controls, posttranslational control via ubiquitin-mediated proteolysis, as well as regulation of the subcellular localization of proteins. A Cdk molecule binds to an activator molecule known as a cyclin, which is an absolute requirement for Cdk activation. In addition, Cdks are regulated by site-specific phosphorylation and by the binding of Cdk inhibitors. This phosphorylation elicits a conformational change that, together with cyclin binding, is required for kinase activity. Cdk-activating kinase is active throughout all phases of the cell cycle, but its access to the Cdk substrate is cell cycle regulated. These processes are controlled through the 70 cell cycle by the interplay between the Wee-1 and Myt-1 kinases and a group of cell division cycle (Cdc) phosphatases Cdc25A, B, and C. Activation of Cdks by binding to cyclins the family of mammalian cyclins (A to H) all shares a conserved sequence of about 100 amino acids, referred to as the cyclin box. Different cyclins bind and activate different Cdks, and activated cyclin-Cdk complexes, in turn, phosphorylate various target proteins to ultimately mediate progression through the different cell cycle phases.